Physician profile
Alyssa Jackson
NPI 1174053433
$1,506.16
in general payments reported to CMS, 2019-2025
15 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.71 · 2020: $109 · 2021: $196 · 2022: $196 · 2023: $233 · 2024: $391 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849 · Entertainment: $66.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.76 |
| Entertainment | $66.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $410.99 | 2019-2025 | Acuvue |
| Coopervision INC. | $353.71 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $161.80 | 2020-2024 | Total30, Precision 7 |
| Bausch & Lomb Americas INC. | $128.71 | 2022-2025 | Biotrue One Day, Miebo, Xiidra |
| Lkc Technologies, INC. | $114.55 | 2024 | |
| Optos, INC. | $66.50 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $54.94 | 2023-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $43.19 | 2023-2025 | |
| Glaukos Corporation | $34.34 | 2022 | |
| Shire North American Group INC | $27.85 | 2019 | |
| Harrow Eye, LLC | $27.75 | 2024 | Vevye |
| Dompe US, INC. | $23.23 | 2024 | Oxervate |
| Kala Pharmaceuticals, INC. | $22.90 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.26 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.